Bluefin Capital Management LLC purchased a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,332 shares of the medical equipment provider’s stock, valued at approximately $2,835,000. Integer accounts for 0.7% of Bluefin Capital Management LLC’s holdings, making the stock its 22nd biggest position.
A number of other institutional investors and hedge funds have also recently modified their holdings of ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Integer by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock valued at $2,539,000 after acquiring an additional 837 shares during the last quarter. Millennium Management LLC boosted its stake in shares of Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock valued at $14,531,000 after purchasing an additional 118,224 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of Integer by 79,888.9% during the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after purchasing an additional 7,190 shares during the period. United Services Automobile Association bought a new position in shares of Integer in the first quarter worth about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Integer by 4.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after purchasing an additional 4,873 shares during the last quarter. 99.29% of the stock is owned by institutional investors.
Integer News Roundup
Here are the key news stories impacting Integer this week:
- Positive Sentiment: Zacks raised its FY2026 EPS forecast to $6.13 from $6.05 and increased its estimates for Q2 2027 and Q1 2028 to $1.61 and $1.71, respectively. These upward revisions provide some support for the outlook.
- Neutral Sentiment: Zacks maintained a “Hold” rating on Integer. Its current full-year consensus EPS estimate is approximately $6.08, while the firm projects FY2027 EPS of $6.56 and FY2028 EPS of $6.85, indicating continued earnings growth but limited near-term conviction.
- Negative Sentiment: Zacks reduced estimates for Q3 2026 EPS to $1.63 from $1.68, Q4 2026 EPS to $1.70 from $1.77, Q1 2027 EPS to $1.46 from $1.50, Q3 2027 EPS to $1.72 from $1.87, Q4 2027 EPS to $1.77 from $1.90, FY2027 EPS to $6.56 from $6.87, and FY2028 EPS to $6.85 from $7.20. The broad reductions, particularly to full-year 2027 and 2028 forecasts, are likely the main reason the stock has weakened.
Integer Trading Down 0.1%
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The company had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. During the same quarter last year, the company earned $1.55 earnings per share. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Integer Holdings Corporation will post 6.09 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Raymond James Financial lowered shares of Integer from a “moderate buy” rating to a “hold” rating in a report on Monday, August 3rd. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. KeyCorp lowered shares of Integer from an “overweight” rating to a “sector weight” rating in a research report on Monday, August 3rd. Freedom Capital downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. One research analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $109.86.
Get Our Latest Analysis on ITGR
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
- Five stocks we like better than Integer
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
